Calcium Gluconate Injection Market Size, Share, Growth, and Industry Analysis, By Type (10ml：1g, 50ml：5g and 100ml：10g), By Application (Hospital, Clinic and Others) and Regional Forecast to 2033

CALCIUM GLUCONATE INJECTION MARKET REPORT OVERVIEW

Calcium Gluconate Injection Market Size was estimated at USD 167.19 million in 2024 and it is expected to grow from USD 181.74 million in 2025 to USD 214.73 million by 2033. The Market CAGR (growth rate) is expected to be around 8.7% during the forecast period (2025 - 2033).

Calcium gluconate injection is a clinical intravenous medicine that can meet various clinical needs, but the main function is to supplement the blood and blood calcium. Its work is based on its ability to manage different diseases such as hypocalcemic, acute hypocalcemia, alkali poisoning and tetany resulting from hypothyroidism. Calcium gluconate compensates for these imbalances by rapidly infusing required calcium ions intravenously to tactfully manage such vital processes as muscle contractions, nerve impulses and coagulation. Additionally, it is utilised in the treatment of allergic disorders because this hormone has the effect of decreasing allergies due to immune system modulation.

In addition, calcium gluconate has its major use as a measure in managing cases of magnesium overdosage. It is also important to know that magnesium toxicity impacts the neuromuscular and cardiovascular system and as such, obtaining high amounts of magnesium in the bloodstream is always detrimental. Calcium gluconate neutralises the concentrations of magnesium and promotes the return to the physiological relationships to prevent such dangerous states. This suggests the relevance of the drug in contemporary practice where it provides clinicians with a means of approaching a myriad of clinical scenarios, ranging from calcium depletion and allergies to even hypermagnesemia.

• • 

    Request a Free sample to learn more about this report.

COVID-19 Impact: Consumer spending decreased during the pandemic which lowered the demand in the market

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.

The pandemic led to a significant reduction in consumer expenditure across many sectors, which comprised beauty and personal products and foods and beverages. Due to such factors as liquidity shortages and personal restrictions on non-essential expenditures, many industries started experiencing a decline in the usage of calcium gluconate-containing products. Due to the containment measures, several cosmetics and personal care products are seen as non-essentials during such periods resulting in low use of calcium gluconate in the production of their formulations. In the same respect, the food and beverage market experienced a trend change where people preferred necessities, implying that there was low demand for calcium gluconate for use as a food supplement or enhancer. This decrease further affirmed the effect of the pandemic on the different fields of the economy.

LATEST TRENDS

"Demand for calcium supplements to drive the market"

There is increased demand in the market for calcium supplements, especially among the elderly and people with low consumption of calcium intake. Due to ageing, there are increased cases of bone conditions such as osteoporosis and bone breaks therefore the need for adequate calcium intake to maintain the bones. Calcium gluconate and other such supplements are in demand especially for the elderly population to maintain their bone health. Also, people with dietary restrictions or ailments that can limit their calcium intake receptors require such supplements to get the necessary nutrients. Such awareness regarding the importance of calcium in building strong bones and in general well-being in conjunction with the recommendation from health care professionals put forward are the chief causes behind the rising popularity and sales of calcium supplements regardless of age and health conditions.

• • 

    Request a Free sample to learn more about this report.

CALCIUM GLUCONATE INJECTION MARKET SEGMENTATION

By Type

Based on type the global market can be categorized into 10ml：1g, 50ml：5g and 100ml：10g.

• 10ml：1g: The 10ml: 1g calcium gluconate injection is vital for rapidly treating acute hypocalcemia and emergencies needing quick calcium replenishment. Its small volume makes it perfect for immediate use in emergency rooms and pediatric or adult patients needing precise, lower doses. Compact and easy to store, this formulation is ideal for swift administration and is practical for healthcare providers.

• 50ml：5g: The 50ml: 5g calcium gluconate injection offers a moderate-strength dose suitable for substantial, yet not immediate, calcium correction. It's commonly used for moderate hypocalcemia and in treatment regimens requiring consistent calcium supplementation such as dialysis. Administered as a slow infusion, it ensures steady calcium increase without rapid injection risks. Suited for adults with higher calcium needs or chronic conditions, it's indispensable in emergency and long-term care settings.

• 100ml：10g: The 100ml: 10g calcium gluconate formulation caters to high-dose calcium supplementation, crucial for addressing severe deficiencies or specific medical treatments requiring significant calcium quantities. It finds extensive use in treating severe hypocalcemia, severe alkalosis or cases demanding large-scale calcium replenishment. Typically administered via extended infusion, it ensures patient safety and gradual calcium absorption, making it indispensable in intensive care units and specialized medical treatments.

By Application

Based on application the global market can be categorized into Hospital, Clinic and Others.

• Hospital: Hospitals heavily depend on calcium gluconate injections for acute interventions, emergency care and specialized treatments. In emergency departments, they manage severe hypocalcemia, tetany and calcium channel blocker overdoses. In surgical settings, they counteract blood loss and calcium depletion. In intensive care units, they are in charge of patients who have severe diseases and most delicate procedures such as cardiac arrest and magnesium toxicity.

• Clinic: As for outpatient care, clinics prescribe calcium gluconate injections for osteoporosis treatment, vitamin D deficiency and as a means of calcium level regulation in such chronic diseases as renal failure. They are also used in allergy and endocrinology clinics for desensitization therapy and controlling disorders such as hyperparathyroidism. Wellness clinics offer them as part of nutritional therapy or to address deficiencies, reflecting their importance in holistic healthcare.

• Others: Clinics commonly use calcium gluconate injections for osteoporosis, vitamin D deficiency and managing chronic conditions such as renal failure. They're pivotal in allergy and endocrinology clinics for desensitization therapy and treating disorders such as hypoparathyroidism. Wellness clinics integrate them into nutritional therapy, emphasizing their holistic healthcare approach outside hospital settings.

DRIVING FACTORS

"Increase in awareness regarding bones and health to drive the market"

The growing concern in people about their bones and joints in later times has increased demand for the global Calcium Gluconate Injection Market growth as a nutritional supplement. With modern society becoming more conscious of its health status, there has been increased concern about the importance of calcium intake in the development of good bones. Patients have become more conscious of the fact that they have problems such as osteoporosis or fractures, and therefore they are searching for the best supplementation products. Calcium gluconate has become more popular over the years because it is effective and well-known for strengthening bones and it is easily obtained. This trend tells about a changing image of society towards the utilization of preventive healthcare measures. Taking calcium gluconate supplements puts such a person among the first-line preventive mechanisms against any bone-related issues in future. Thus, the use of calcium gluconate suggests the improved awareness of people towards their and their reflections involving bones as a part of their healthy lifestyles.

"Improvement in manufacturing technology to increase the market"

The advanced manufacturing technologies seen in production have noted a corresponding progress in the manufacturing of calcium gluconate. The manufacturers are now in a better position to produce large quantities of calcium that has complexing agents being gluconate in greater quality and efficiency than it has ever been before due to the adoption of efficient processes and more automation. These technological enhancements have improved the flow of production processes leading to one-of-a-kind production rates, less time and cost as compared to greater productivity. Business entities that have adopted these developments enjoy the benefits of being in a position to produce high-quality calcium gluconate at cheaper prices than their rivals. Further, these manufacturing technologies can expand to accommodate increased market demands and fully satisfy clients’ needs. In conclusion, the use of technology in the manufacturing of calcium gluconate has served to improve the quality of the final product and also has a positive effect on the market position of firms that innovate in these technologies which has led to improved market share and profitability.

RESTRAINING FACTORS

"High initial investment needed in the development and manufacturing of the injections poses a threat to the market"

Calcium gluconate injections are manufactured involving very high initial investment that acts as barriers to the entry of new players. The cost of establishing a facility that deals with the production of drugs, purchasing advanced equipment and meeting certain expenses as recommended by legal requirements is highly expensive. Operating expenses are also relatively high due to involvement in research and development, which determines product effectiveness and quality. Maintenance costs involved in quality assurance and meeting legal requirements add to the pressure of the new entrant’s limit of resources. As a result of this, there is limited competition and market share is taken up by larger and more established pharmaceutical firms. New entrants experience immense difficulty in penetrating the market without large amounts of funding which creates difficulties in market entry. The large capital investment required is prohibitive to firms that would otherwise establish themselves in the calcium gluconate injection market, thus regulating competition and entry.

• • 

    Request a Free sampleto learn more about this report.

CALCIUM GLUCONATE INJECTION MARKET REGIONAL INSIGHTS

The market is primarily segregated into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.

"North America is dominating the market due to the advancement and research and development activities in the pharma industry"

The global Calcium Gluconate Injection Market share is expected to witness significant growth in its North America market owing to the increasing interest and research towards the medicinal use of calcium gluconate injection in the treatment of diseases such as hypocalcaemia and hyperkalemia in the pharmaceutical industry. There is a significant amount of research available on the pharmacodynamics of calcium gluconate in these medical ailments and research is still on to understand its therapeutic effects and in vitro and in vivo efficacy along with clinical trials that propose the therapeutic value and the toxicological potential of calcium gluconate is in the process of being researched. As of now, pharmaceutical companies in the region are investing in the concept development of new and advanced formulations of calcium gluconate with enhanced bio-pharmacokinetic properties and therapeutic profiles. This increasing focus on research regarding calcium gluconate shows intent for it as a therapeutic agent and is indicative of the pharmaceutical industry’s aim to consistently innovate and enhance the care of patients in the region.

KEY INDUSTRY PLAYERS

"Key industry players are enhancing strategic partnerships along with new product development to fuel the market"

Key industry players in the market continue to integrate strategic partnerships and new product development to gain competitive advantage and foster innovation. This strategy involves working with other key players in the industry or those in related industries whereby the involved firms can gain the required resources, skills and markets that will help improve their products and access more markets. These strategic partnerships also offer the advantages of resource integration and risk-sharing, thus shortening the new product development and commodification cycle of products. Moreover, sustained capital expenditure in research and development allows the company to launch new products and create novel forms of medicine to meet the changing healthcare requirements and accommodations. Thus, leading players are expected to solidify their major market standing through actions such as strategic partnerships and new product releases, as well as sufficiently meet the increasing demand for calcium gluconate Injection and bolster market growth.

List Of Market Players Profiled

• Fresenius Kabi USA (U.S.)
• Shalina Laboratories (U.A.E)
• Brilliant Pharma (Egypt)
• Kokad Pharmaceutical Laboratories (India)
• Huiyinbi Group (China)
• CR Double-Crane (China)
• Medchk (China)
• Sinopharma (China)
• Tiancheng Pharma (China)
• King York (China)

INDUSTRIAL DEVELOPMENT

May 2024: Angels for Change honoured Fresenius Kabi USA with the 2024 Drug Shortage Guardian Award for its exceptional response during chemotherapy shortages in 2024. This award recognizes organizations and individuals who prioritize patient needs during drug shortages. Karen Twardzik and Danielle Gross from Fresenius Kabi were also individually recognized. John Ducker, CEO of Fresenius Kabi, expressed gratitude and commitment to combating medicine shortages. The awards were presented at Fresenius Kabi's U.S. headquarters and Melrose Park manufacturing site.

REPORT COVERAGE

The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.

The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.

"